Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025

RIO DE JANEIRO, Oct. 9, 2025 /PRNewswire/ -- Anbio Biotechnology participated in the 50^th World Small Animal Veterinary Association Congress (WSAVA 2025), an international gathering that brought together veterinarians, researchers, and industry representatives from more than 100 countries. The event provided a platform for Anbio to present its veterinary diagnostic portfolio and exchange views with partners across global markets.

At WSAVA 2025, Anbio displayed five product lines:

• Fluorescence Immunoassay (FIA)
• Dry Chemistry
• Molecular Diagnostics
• Colloidal Gold Rapid Tests
• Dry Chemiluminescence Immunoassay (CLIA)

The portfolio generated interest among veterinarians, distributors, and industry participants. The dry chemiluminescence and fluorescence immunoassay systems were noted for their precision and usability, while discussions with distributors reflected demand for accessible and accurate testing technologies in veterinary healthcare.

A key feature was Anbio's molecular diagnostics platform, capable of producing multi-target real-time PCR results within 15 minutes. This function was highlighted as a practical option for the rapid detection of respiratory and infectious diseases in animals, where timely results are critical to clinical management. Delegates pointed to the relevance of such technologies in strengthening outbreak response and supporting routine diagnostic workflows.

The exhibition also provided opportunities for Anbio to engage with existing and potential partners, discuss distribution strategies, and consider future product rollouts. These exchanges underlined the increasing role of point-of-care diagnostics in veterinary practice and emphasized the importance of international collaboration in expanding access to diagnostic tools.

Looking ahead, Anbio will continue its global outreach. The company is scheduled to participate in the Wild West Vet Show 2025, taking place from October 15–18, 2025, in Reno, Nevada, USA. The exhibition will provide another opportunity to present its veterinary diagnostic portfolio and to interact with professionals from the North American market.

Anbio's participation in WSAVA 2025 reflects its continuing efforts in both human and veterinary diagnostics. By advancing practical and reliable testing solutions, the company contributes to improving healthcare outcomes in diverse settings worldwide.

About Anbio Biotechnology
Anbio Biotechnology is a globally oriented in vitro diagnostics (IVD) company providing a broad range of solutions, including immunofluorescence, dry chemistry, chemiluminescence, molecular diagnostics, rapid testing and veterinary diagnostics. With operations across multiple regions, the company works to enhance the availability of reliable and timely diagnostics, supporting better decision-making in healthcare settings worldwide.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025

SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- HOTELEX Shanghai 2026 will take place from 30^th March to 2^nd April 2026, offering global hospitality and foodservice suppliers a direct gateway to China and the wider Asian market. Building on the record-breaking success of the 2025 edition, the exhibition will return with expanded scale, stronger international buyer engagement, and enhanced commercial value. With over 3,500 exhibitors, 12,000 overseas buyers, and a fully integrated industry ecosystem, HOTELEX Shanghai 2026 provides a high-impact platform for sourcing, partnerships, and long-term market expansion.

HOTELEX Shanghai 2025 welcomed a record 284,581 professional visitors, including a 34.2% increase in international buyers. Exhibitors reported a 37% rise in qualified leads and a 23% increase in on-site transactions, demonstrating the exhibition's effectiveness as a high-performance sourcing and business platform. Building on this success, the 34ᵗʰ edition in 2026 will offer expanded exhibition space, deeper international participation, and increased opportunities for global decision-makers, distributors, and strategic partners.

Covering 400,000 square meters, the exhibition will host more than 3,500 leading domestic and international suppliers across key sectors including Kitchen Equipment, Coffee & Tea, Catering Ingredients, Beverages, and Baking Supplies. This fully integrated ecosystem supports end-to-end sourcing, innovation, and cross-border collaboration.

HOTELEX's competitive advantage lies in its comprehensive industry coverage. By integrating resources across hospitality, catering, cultural tourism, retail, logistics, and health sectors, the exhibition drives value-chain synergies and reflects the evolving structure of the modern hospitality economy. Its distinctive "tourism–catering–hotel joint exhibition" model offers a holistic showcase spanning food, accommodation, travel, shopping, and leisure.

Leveraging a shared pool of over 100,000 professional buyers from HOTELEX and FHC, exhibitors gain extended brand exposure through official digital platforms and global social media channels including LinkedIn, YouTube, Facebook, and TikTok, as well as partnerships with authoritative industry media. Booths are limited – reserve yours early to secure prime exhibition space and maximize business opportunities. Positioned as a strategic gateway, HOTELEX Shanghai 2026 empowers global companies to grow their presence in China and accelerate expansion across Asia's hospitality and foodservice markets.

Pre-registration: https://www.hotelex.cn/en/shanghai

Contact Us：
Booth Inquiry:
Jason Jin
Tel: +86 21 3339 2197
Junyan.Jin@imsinoexpo.com

Media & Visitor Consulting:
Lizzy Chen
Tel: +86 21 3339 2566
Lizzy.chen@imsinoexpo.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Maximize Your Business Growth in Asia's Hospitality & Foodservice Market at HOTELEX 2026